Mistletoe and the Emerging Future of Integrative Oncology

Nasha Winters is a global healthcare authority and best-selling author in integrative cancer care and research. She is currently planning for a comprehensive metabolic oncology hospital and research institute in the US. She lives in Colorado, USA. Steven Johnson directed one of the first inpatient integrative medicine clinics in the US and now directs the first European Mistletoe/Integrative Medicine Training Program in North America. He lives in New York, USA.

C O N T E N T S:

How to Use this Book
Foreword by Dr Luis A Diaz
Introduction by Dr Steven Johnson, DO

PART 1: THE LANDSCAPE OF MISTLETOE THERAPY

1. Ancient Plant, Modern Therapy:
A Brief History of Mistletoe and Modern Oncology
Dr Steven Johnson, DO and Dr Nasha Winters, ND, FABNO

2: The Immunology and Science of Mistletoe
Dr Paul Faust, ND

3: The State of Current Mistletoe Research
Dr Paul Faust, ND and Dr Marion Debus, MD

PART 2: MISTLETOE IN CLINICAL PRACTICE

4: Understanding Host Trees:
Best Practices in Choosing Mistletoe Therapies
Dr Peter Hinderberger, MD

5: Test, Assess, Address . . . Don’t Guess! Adjusting Treatment
Priorities in Response to the Patient's Unique Terrain
Dr Nasha Winters, ND, FABNO

PART 3: HUMAN-CENTERED MEDICINE

6: The Physiology of Warmth
Dr Adam Blanning, MD

7: What is 'Constitutional Care' in the Anthroposophic World?
Seeing the Whole person, the Whole Human Organism, before Providing Care
Dr Peter Hinderberger, MD

8: Pairing AM Adjuvants:
Helleborus and Other Anthroposophic Remedies Provided alongside Mistletoe Therapy
Dr Steven Johnson, DO

9: Building the Bridge between Mistletoe and
Other Integrative Therapies
Dr Nasha Winters, ND, FABNO

PART 4: WEAVING IT ALL TOGETHER: SPECIAL APPLICATIONS IN CLINICAL PRACTICE

10: Unique Scenarios: Novel Mistletoe Administration Routes and Understanding Tissue-origins of Specific Cancer Types
Dr Mark Hancock, MD and Dr. Marion Debus

11: Using Mistletoe Therapy in Advanced Disease and End-of-Life Care
Dr Steven Johnson, DO

12: What the Horizon Holds for Mistletoe Therapy . . . And for an Expanding Integrative Approach to Cancer Care
Dr Nasha Winters, ND, FABNO

Afterword by Holly Lucille, ND, RN

APPENDICES
A: Basics of Mistletoe Administration
B: Dramatic Responses to VAE Therapy
C: Anamnestic Form
D: MD Anderson Prognostic Scoring System
E: Host Trees and Cancer Types: Basic Matching Guidelines
F: Terrain-centric Core Lab Tests and True Healthy Ranges